FNDC5 and type 2 diabetes mellitus: In another recent study, a decrease in irisin was noted in patients with NAFL, type 2 diabetes mellitus (T2DM), and those with both NAFL and T2DM, in a comparison with a control group, and a negative correlation between irisin and visceral adiposity was reported [10].